[What is the current status of therapeutic possibilities in severe juandice?].
D000293:Adolescent; D000328:Adult; D002648:Child; D003065:Coenzyme A / Q000627:therapeutic use; D005078:Exchange Transfusion, Whole Blood; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D006931:Hyperbaric Oxygenation; D007565:Jaundice / Q000209:etiology / Q000628:therapy*; D007688:Kidneys, Artificial; D008099:Liver; D008107:Liver Diseases / Q000150:complications; D008875:Middle Aged; D009243:NAD / Q000627:therapeutic use; D010477:Perfusion; D010530:Peritoneal Dialysis; D011239:Prednisolone / Q000627:therapeutic use; D013835:Thiamine Pyrophosphate / Q000627:therapeutic use; D008063:Thioctic Acid / Q000627:therapeutic use
D009243:NAD; D008063:Thioctic Acid; D011239:Prednisolone; D013835:Thiamine Pyrophosphate; D003065:Coenzyme A; D006854:Hydrocortisone
Quel est l'état actuel des possibilités thérapeutiques dans les ictères graves?